Skip to content

Evaluation of the Effect of Repeated Usage on the Tear Film Characteristics of an Investigational Eye Drop in Dry Eye Sufferers

Status
Completed
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01339936
Enrollment
40
Registered
2011-04-21
Start date
2011-03-31
Completion date
2012-05-31
Last updated
2013-11-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry Eye Syndrome

Brief summary

The main objectives of the investigation will be to assess the effect of the repeated usage of an investigational eye drop on the tear film characteristics of dry eye sufferers and demonstrate the benefit of this eye drops for dry eye sufferers.

Interventions

DEVICECarboxymethylcellulose sodium, glycerin and polysorbate 80

1 drop in each eye three times a day for a period of 30 (± 4) days

Sponsors

Allergan
CollaboratorINDUSTRY
Optometric Technology Group Ltd
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Mild or greater dry eye symptoms. * Evidence of evaporative dry eye

Exclusion criteria

* Known allergy or sensitivity to the study product(s) or its components * Current contact lens wearer * Systemic or ocular allergies * Use of systemic medication which might have ocular side effects. * Any ocular infection. * Use of ocular medication.

Design outcomes

Primary

MeasureTime frameDescription
Tear Film Evaporation Rateafter 30 days of eyedrop usageThe rate of evaporation of the tears from the ocular surface was measured. To do so the participant was required to wear a sealed goggle over the eye, which served to isolate the air surrounding the ocular surface. The temperature and humidity were measured within the sealed goggle during closed eye and open eye situations. The evaporation from the ocular surface was calculated by taking the difference between the evaporation rate of the skin taken during the closed eye measurement and the evaporation rate taken during the open eye measurement. The rate of evaporation was measured in 10\^-7 g/cm\^2 /s and recorded for relative humidity of 25% to 35%.

Secondary

MeasureTime frameDescription
Tear Break Up Timeafter 30 days of eyedrop usageThe tear film break-up-time (BUT) is the time elapsed between eye opening after a blink, and the appearance of the first dark spot within the tear film when observed with a wide diffuse light source of the Tearscope. This measurement is indicative of the tear film stability. Three independent measurements were recorded in each case and the median value over the three measurements calculated. The latter value constituted the secondary endpoint used in the analysis.
Ocular Surface Disease Index Scoreafter 30 days of eye drop usageThe OSDI is a 12-item patient-reported outcomes questionnaire designed to assess the range of ocular surface symptoms, their severity, and their impact on the patient's ability to function. The OSDI items are scored on a 0 to 4 Likert-type scale, where 0 = None of the time, 1 = Some of the time, 2 = Half of the time, 3 = Most of the time, and 4 = All of the time. Using individual item responses, an overall OSDI score is calculated. The overall OSDI score ranges from 0 to 100, where a score of 100 corresponds to complete disability while a score of 0 corresponds to no disability.

Countries

United Kingdom

Participant flow

Recruitment details

The subjects were selected from the existing clinical population of Optometric Technology Group Ltd (OTG Research & Consultancy). The subjects, fulfilling the criteria for inclusion were invited in a random fashion to participate in the study until the test population was achieved.

Participants by arm

ArmCount
Investigational Eye Drop
Formulation 1: Carboxymethylcellulose sodium, glycerin and polysorbate 80 based eye drops formulated for the relief of ocular surface irritation and symptoms of dryness
35
Total35

Baseline characteristics

CharacteristicInvestigational Eye Drop
Age, Categorical
<=18 years
1 Participants
Age, Categorical
>=65 years
6 Participants
Age, Categorical
Between 18 and 65 years
28 Participants
Age Continuous49 years
STANDARD_DEVIATION 16
Region of Enrollment
United Kingdom
35 participants
Sex: Female, Male
Female
27 Participants
Sex: Female, Male
Male
8 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
3 / 36
serious
Total, serious adverse events
0 / 36

Outcome results

Primary

Tear Film Evaporation Rate

The rate of evaporation of the tears from the ocular surface was measured. To do so the participant was required to wear a sealed goggle over the eye, which served to isolate the air surrounding the ocular surface. The temperature and humidity were measured within the sealed goggle during closed eye and open eye situations. The evaporation from the ocular surface was calculated by taking the difference between the evaporation rate of the skin taken during the closed eye measurement and the evaporation rate taken during the open eye measurement. The rate of evaporation was measured in 10\^-7 g/cm\^2 /s and recorded for relative humidity of 25% to 35%.

Time frame: after 30 days of eyedrop usage

Population: The analysis was carried out on subjects having completed the study according to the protocol e.g. 35

ArmMeasureValue (MEAN)Dispersion
Investigational Eye DropTear Film Evaporation Rate26.0 10^-7g/cm^2/secStandard Deviation 11.2
Secondary

Ocular Surface Disease Index Score

The OSDI is a 12-item patient-reported outcomes questionnaire designed to assess the range of ocular surface symptoms, their severity, and their impact on the patient's ability to function. The OSDI items are scored on a 0 to 4 Likert-type scale, where 0 = None of the time, 1 = Some of the time, 2 = Half of the time, 3 = Most of the time, and 4 = All of the time. Using individual item responses, an overall OSDI score is calculated. The overall OSDI score ranges from 0 to 100, where a score of 100 corresponds to complete disability while a score of 0 corresponds to no disability.

Time frame: after 30 days of eye drop usage

ArmMeasureValue (MEAN)Dispersion
Investigational Eye DropOcular Surface Disease Index Score26.8 pointsStandard Deviation 23
Secondary

Tear Break Up Time

The tear film break-up-time (BUT) is the time elapsed between eye opening after a blink, and the appearance of the first dark spot within the tear film when observed with a wide diffuse light source of the Tearscope. This measurement is indicative of the tear film stability. Three independent measurements were recorded in each case and the median value over the three measurements calculated. The latter value constituted the secondary endpoint used in the analysis.

Time frame: after 30 days of eyedrop usage

Population: The analysis was carried out on subjects having completed the study according to the protocol e.g. 35

ArmMeasureValue (MEAN)Dispersion
Investigational Eye DropTear Break Up Time5.8 secondsStandard Deviation 4.3

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026